VALAROX 10mg / 80mg tablets medication leaflet

C10BX10 rosuvastatin + valsartan • Cardiovascular system | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Rosuvastatin+valsartan is a combination medication used for the treatment of dyslipidemia and hypertension. Rosuvastatin is an HMG-CoA reductase inhibitor that lowers LDL cholesterol and triglycerides while increasing HDL cholesterol. Valsartan is an angiotensin II receptor antagonist that helps relax blood vessels and lower blood pressure.

This combination is taken orally, usually once daily, and is indicated for patients requiring both lipid and blood pressure control. It is commonly used to reduce overall cardiovascular risk, including the risk of myocardial infarction and stroke.

Common side effects include headache, dizziness, nausea, and muscle pain. In rare cases, severe adverse reactions such as kidney failure or rhabdomyolysis may occur. Regular monitoring of renal function and lipid profile is essential.

Rosuvastatin+valsartan is an effective therapeutic option for patients at high cardiovascular risk, offering multiple benefits in a single administration.

General data about VALAROX 10mg / 80mg

Substance: rosuvastatin + valsartan

Date of last drug list: 01-06-2017

Commercial code: W63419010

Concentration: 10mg / 80mg

Pharmaceutical form: tablets

Quantity: 100

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: KRKA D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 9604/2017/10

Shelf life: 2 years

Concentrations available for rosuvastatin + valsartan

10mg/160mg, 10mg/80mg, 20mg/160mg, 20mg/80mg